Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Minority Interest: 2023-2025

  • Zhengye Biotechnology Holding's Minority Interest was N/A to $9.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $9.1 million, marking a year-over-year change of. This contributed to the annual value of $9.5 million for FY2024, which is 1.55% up from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Minority Interest stood at $9.1 million for Q2 2025, which was down 2.66% from $9.4 million recorded in Q4 2024.
  • In the past 5 years, Zhengye Biotechnology Holding's Minority Interest ranged from a high of $9.4 million in Q4 2024 and a low of $9.1 million during Q2 2025.
  • Moreover, its 3-year median value for Minority Interest was $9.2 million (2023), whereas its average is $9.3 million.
  • Data for Zhengye Biotechnology Holding's Minority Interest shows a peak YoY climbed of 1.87% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Minority Interest (Quarterly) stood at $9.2 million in 2023, then increased by 1.87% to $9.4 million in 2024, then reached $9.1 million in 2025.
  • Its Minority Interest was $9.1 million in Q2 2025, compared to $9.4 million in Q4 2024 and $9.2 million in Q4 2023.